Endobronchial cancer are characterized by small size, slow growth and usually misdiagnosed as asthma or chronic bronchitis due to their common symptoms. These cancers are usually benign and rare. Due to these reasons, they may remain undiagnosed for a long time and lead to serious complications. The term bronchial adenoma encompasses a diverse group of tumors of mucous glands, trachea or bronchi. Common symptoms of endobronchial cancer include difficulty in breathing (dyspnea), wheezing due to obstructed windpipe, cough and in some cases fever. Cigarette smoking and alcohol addiction have been found to be in close association of endobronchial cancer. Scientists also suggest that various lung cancer cases have shown endobronchial metastases.  
 
The cancer is diagnosed through various radiology tests such as X-ray, computed tomography (CT) or magnetic resonance imaging (MRI). Octreotide scan, also known as somatostatin receptor scintigraphy, is also used for diagnosis of endobronchial cancer. It is a non-invasive diagnostic method used to detect presence of tumor cells. Bronchoscopy is a routine method to visualize cancer growth. A bronchoscope is a thing flexible tube which possesses a camera at its tip. A clear image of the cancer and its progression can be obtained through bronchoscopy method. Tissue biopsy by endoscopic methods also helps in gaining more insight to cancer type and its further assessment.
 
Surgical removal of the cancer can be done through open lung surgeries or endoscopic methods. Although choice depends on size and nature of the tumor. Small and localized tumor can be excised through bronchoscopic surgeries. Certain tumors can also be ablated through laser treatment. This method is usually accompanies with chemotherapy, as there are chances of cancer relapse. 
 
Brachytherapy, Argon beam coagulation, photodynamic therapy and other radiation methods have also shown promising results in treating endobronchial cancer. Steba Biotech S.A. is conducting phase II clinical trials for its investigational drug WST11. Pinnacle Biologics manufactured PHOTOFRIN (porfimer sodium) has been widely employed in photodynamic therapy for treating endobronchial cancer. Pinnacle Biologics has also received FDA approval for the treatment of oesophageal and endobronchial cancer and high-grade dysplasia in barrett’s oesophagus.
 
Cancer has been a major cause of mortalities worldwide. World Health Organization (WHO) suggests that 60% of the new cases occur in Africa, Asia and Central and South America. Over 8 million mortalities were recorded in 2012 globally, with lung cancer accounting for approximately 3 million cases, while oesophageal cancer accounting for 400,000 deaths worldwide. Over one-fifth of all cancer cases are diagnosed in India. Despite high smoking rate, prevalence of lung cancer in China is lower than European countries. According to Cancer Research, U.K., approximately 43,000 individuals in the UK were diagnosed with lung cancer in 2011. Such high prevalence of cancer has demanded for quicker and effective treatment. Advances in biotechnology have introduced innovative methods of cancer diagnosis and cure, however because of high cost these technologies have not yet available to low and middle income countries. Countries such as India, China, Brazil and Japan have been the most attractive geographies for endobronchial cancer. Japan is the second largest individual healthcare market after the U.S. Constantly developing healthcare sector in China, India and Brazil have created promising opportunities in these countries. Higher cancer prevalence, increasing per capita income and evolving government policies are other factors favoring market growth.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Endobronchial Cancer Market

Pre Book